2015
DOI: 10.1021/acs.jmedchem.5b00925
|View full text |Cite
|
Sign up to set email alerts
|

Nω-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([3H]UR-MK299) with Extended Residence Time

Abstract: Analogues of the argininamide-type NPY Y1 receptor (Y1R) antagonist BIBP3226, bearing carbamoyl moieties at the guanidine group, revealed subnanomolar Ki values and caused depression of the maximal response to NPY (calcium assay) by up to 90% in a concentration- and time-dependent manner, suggesting insurmountable antagonism. To gain insight into the mechanism of binding of the synthesized compounds, a tritiated antagonist, (R)-N(α)-diphenylacetyl-N(ω)-[2-([2,3-(3)H]propionylamino)ethyl]aminocarbonyl-(4-hydrox… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
93
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 24 publications
(95 citation statements)
references
References 37 publications
2
93
0
Order By: Relevance
“…This is supported by studies showing that some other carbamoylated argininamide-type Y 1 R antagonists containing longer carbamoyl chains, such as UR-MK136 (Extended Data Fig. 1j), bind to the receptor with a relatively high affinity 10 .…”
mentioning
confidence: 61%
See 4 more Smart Citations
“…This is supported by studies showing that some other carbamoylated argininamide-type Y 1 R antagonists containing longer carbamoyl chains, such as UR-MK136 (Extended Data Fig. 1j), bind to the receptor with a relatively high affinity 10 .…”
mentioning
confidence: 61%
“…All binding experiments with [ 3 H]-UR-MK299 (synthesis described elsewhere 10 ) were performed at Sf9 membrane preparations in PP 96-well microplates (Greiner bio-one) at 23±1 °C using a sodium-containing, iso-osmotic HEPES buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM KCl, 2.5 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM Mg 2 SO 4 and 25 mM NaHCO 3 supplemented with 1% BSA) for competition binding studies with antagonists, and a sodium-free, hypo-osmotic HEPES buffer (25 mM HEPES, pH 7.4, 2.5 mM CaCl 2 and 1 mM MgCl 2 supplemented with 1% BSA) for competition binding studies with the agonist NPY (in the following, both buffers are referred to as ‘binding buffer’). Prior to competition binding experiments, K d values of [ 3 H]-UR-MK299 were determined by saturation binding using the respective binding buffer.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations